$276 Million is the total value of Ghost Tree Capital, LLC's 40 reported holdings in Q4 2018. The portfolio turnover from Q3 2018 to Q4 2018 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| TGTX | Exit | TG THERAPEUTICS INC | $0 | – | -45,500 | -100.0% | -0.05% | – |
| INSM | Exit | INSMED INC | $0 | – | -26,000 | -100.0% | -0.11% | – |
| SPPI | Exit | SPECTRUM PHARMACEUTICALS INC | $0 | – | -47,200 | -100.0% | -0.17% | – |
| EDGE | Exit | EDGE THERAPEUTICS INC | $0 | – | -1,000,000 | -100.0% | -0.17% | – |
| GRTS | Exit | GRITSTONE ONCOLOGY INC | $0 | – | -75,000 | -100.0% | -0.23% | – |
| FATE | Exit | FATE THERAPEUTICS INC | $0 | – | -75,000 | -100.0% | -0.26% | – |
| AQXP | Exit | AQUINOX PHARMACEUTICALS INC | $0 | – | -500,000 | -100.0% | -0.31% | – |
| AVDL | Exit | AVADEL PHARMACEUTICALS PLCsponsored adr | $0 | – | -450,000 | -100.0% | -0.42% | – |
| NEOS | Exit | NEOS THERAPEUTICS INC | $0 | – | -482,600 | -100.0% | -0.50% | – |
| APLS | Exit | APELLIS PHARMACEUTICALS INC | $0 | – | -185,000 | -100.0% | -0.70% | – |
| ALLK | Exit | ALLAKOS INC | $0 | – | -75,000 | -100.0% | -0.72% | – |
| RDUS | Exit | RADIUS HEALTH INC | $0 | – | -200,000 | -100.0% | -0.76% | – |
| KURA | Exit | KURA ONCOLOGY INC | $0 | – | -230,000 | -100.0% | -0.86% | – |
| ALNY | Exit | ALNYLAM PHARMACEUTICALS INCcall | $0 | – | -50,000 | -100.0% | -0.93% | – |
| GBT | Exit | GLOBAL BLOOD THERAPEUTICS INcall | $0 | – | -150,000 | -100.0% | -1.21% | – |
| GLYC | Exit | GLYCOMIMETICS INC | $0 | – | -400,000 | -100.0% | -1.22% | – |
| PTLA | Exit | PORTOLA PHARMACEUTICALS INC | $0 | – | -300,000 | -100.0% | -1.70% | – |
| ARGX | Exit | ARGENX SEsponsored adr | $0 | – | -125,000 | -100.0% | -2.02% | – |
| ZGNX | Exit | ZOGENIX INC | $0 | – | -200,000 | -100.0% | -2.11% | – |
| ACAD | Exit | ACADIA PHARMACEUTICALS INCcall | $0 | – | -500,000 | -100.0% | -2.21% | – |
| BLUE | Exit | BLUEBIRD BIO INC | $0 | – | -75,000 | -100.0% | -2.33% | – |
| ASMB | Exit | ASSEMBLY BIOSCIENCES INC | $0 | – | -325,000 | -100.0% | -2.57% | – |
| MRTX | Exit | MIRATI THERAPEUTICS INCput | $0 | – | -300,000 | -100.0% | -3.00% | – |
| TSRO | Exit | TESARO INC | $0 | – | -450,000 | -100.0% | -3.73% | – |
| ECYT | Exit | ENDOCYTE INC | $0 | – | -1,100,000 | -100.0% | -4.15% | – |
| PTCT | Exit | PTC THERAPEUTICS INC | $0 | – | -500,000 | -100.0% | -5.00% | – |
| XBI | Exit | SPDR SERIES TRUSTput | $0 | – | -500,000 | -100.0% | -10.19% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR/A filed 2020-04-09
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MIRATI THERAPEUTICS INC | 30 | Q3 2023 | 7.3% |
| ASCENDIS PHARMA A/S - ADR | 28 | Q3 2023 | 11.8% |
| BIOCRYST PHARMACEUTICALS INC | 25 | Q2 2023 | 2.4% |
| AMICUS THERAPEUTICS INC | 23 | Q3 2023 | 5.6% |
| SAREPTA THERAPEUTICS INC | 22 | Q3 2023 | 9.1% |
| SPDR SER TR | 20 | Q3 2022 | 16.9% |
| IOVANCE BIOTHERAPEUTICS INC | 18 | Q2 2023 | 5.5% |
| ROCKET PHARMACEUTICALS INC | 18 | Q2 2023 | 6.1% |
| SAGE THERAPEUTICS INC | 18 | Q1 2021 | 4.8% |
| IMMUNOMEDICS INC | 17 | Q2 2020 | 8.7% |
View Ghost Tree Capital, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-16 |
| 13F-HR | 2021-11-15 |
View Ghost Tree Capital, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.